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Ultrasound is the recommended staging modality for papillary thyroid cancer. Surgeons proﬁcient in US assessment of the neck
andexperiencedinthemanagementofpapillarythyroidcancer(PTC)appearuniquelyqualiﬁedtoassessthelateralcervicallymph
nodes for metastatic disease. Of 310 patients treated for PTC between 2000 and 2008, 109 underwent surgeon-performed ultra-
sound (SUS) of the lateral neck preoperatively. Fine needle aspiration was performed on suspicious lateral lymph nodes. SUS ﬁnd-
ings were compared with FNA cytology and results of postoperative imaging studies. The sensitivity and negative predictive value
of SUS were 88% and 97%, respectively. Four patients were found to have missed metastatic disease within 6 months. No patient
underwent a nontherapeutic neck dissection. SUS combined with US-guided FNA of suspicious lymph nodes can accurately stage
PTC to reliably direct surgical management.
1.Introduction
Papillary thyroid cancer (PTC) is the most common endo-
crine malignancy, and its incidence is increasing [1–3]. An
exceptional cure rate and low recurrence rate begin with
appropriate surgical treatment. The extent of surgery is det-
ermined by lymph node involvement of the central and
lateral neck. Lateral neck disease discovered preoperatively
leads to more aggressive surgery, which includes compar-
tment-oriented lymph node dissection. Complete surgical
resection of all imageable neck disease at the initial operation
decreases likelihood of future surgery for recurrent disease
and may impact survival.
According to current guidelines, all patients undergoing
thyroidectomy for malignancy should undergo preoperative
neck ultrasound (US) of the thyroid and central and lateral
neck lymph basins, followed by ﬁne needle aspiration (FNA)
of suspicious lymph nodes [4]. This practice has been widely
accepted and supported by leading centers [5–11].
As technology improves and physicians of a variety of
specialties become more comfortable with ultrasound, its
use is becoming more common across specialties. Surgeons
routinely perform ultrasound in multiple arenas including
trauma, breast, and vascular surgery [12–16]. In the endo-
crine surgery literature, much has been published about the
accuracy of surgeon-performed ultrasound of thyroid nod-
ules and parathyroid adenomas [17–22]. Although a great
deal of data is available on accuracy of radiology-performed
ultrasound of the lateral neck for papillary thyroid cancer
staging, little is published on the accuracy of surgeon-perfor-
med ultrasound of the lateral neck.
Surgeons who treat thyroid cancer routinely and already
perform neck ultrasound as part of the physical exam seem
uniquelyqualiﬁedtoevaluatethelateralneckinpatientswith
papillary cancer. We hypothesize that surgeon-performed
ultrasound is a reliable method of evaluating the lateral neck
to stage papillary thyroid cancer.
2. Methods
An IRB-approved retrospective chart review was performed
of all patients treated for papillary thyroid cancer at Scott &
White Clinic in Temple, TX, from 2000 to 2008. Patients who
underwentsurgeon-performedultrasoundofthelateralneck
at the time of diagnosis were included in the study. The pre-
operative SUS evaluation was systematically done either at2 Journal of Oncology
the time of the initial diagnosis of papillary thyroid cancer,
while the patient was still on the FNA procedure table or at
the initial outpatient endocrine surgeon consultation for a
recently diagnosed papillary thyroid cancer. Demographic
data including age, gender, body mass index (BMI), and
weight were recorded. All ultrasounds were performed by
one of two endocrine surgeons in the clinic setting. 96% of
the ultrasound examinations were done by the ﬁrst endo-
crine surgeon (2000–2008) and 4% by the second endocrine
surgeon (2004–2008). The portable ultrasound equipment
used varied over the study period including an Acusan with
a 12-megahertz small-part probe (2000–2004), a Toshiba
Nemio2witha14-megahertzsmall-partprobe(2005–2008),
and a Sonosite with a 13-megahertz small-part probe (2007–
2008). All of these ultrasound machines allowed accurate
real-time imaging of lateral cervical lymph nodes.
Surgical clinic notes were reviewed to determine results
of lateral neck ultrasound. Each side of the neck was treated
as an individual event. Nodes were considered suspicious
based on size (any dominant node, typically greater than
1cm), shape (rounded), loss of hyperechoic stripe (fatty
hilum), and presence of calciﬁcations or cystic changes.
Color Doppler assessment of cervical lymph nodes was not
added as part of the examination until late in the study.
FNA of a suspicious lymph node was done using 3 or 4
passes with 25 gauge needles and ultrasound guidance to
sample the most suspicious areas of the lymph node and
also diﬀerent areas of the lymph node. These samples were
immediately processed by a pathology technician and then
promptly interpreted by a staﬀ cytopathologist in the same
procedure room for adequacy of the FNA sample, as well as
to provide a diagnosis. When FNA was performed based on
ultrasound suspicion, the lateral neck was deﬁned as ultra-
sound-positive. Ultrasound ﬁndings were compared to cyto-
pathologic results of FNA. If both were positive, it was recor-
ded as a true positive. If ultrasound was positive and FNA
negative, it was recorded as a false positive.
Postoperative imaging was used to evaluate the ultra-
sound-negativelateralneck.Short-termimagingconsistedof
radioactive iodine scans immediately before or after radioac-
tive iodine ablation. Long-term followup consisted primarily
of periodic radiology-performed ultrasound of the lateral
neck followed by FNA of any suspicious nodes. Persistent
(missed) disease was classiﬁed as disease discovered in an
ultrasound-negative neck within 6 months of surgery. True
negatives were ultrasound-negative necks that had no evi-
dence of persistent disease. False negatives were ultrasound-
negative necks in which disease was discovered within 6
months of surgery.
3. Results
Of 310 patients with papillary thyroid cancer treated during
the time period, 109 met inclusion criteria. The majority
of exclusions were due to lack of surgeon-performed ultra-
sound of the lateral neck for two primary reasons: incidental
diagnosis of PTC on ﬁnal pathology and initial surgery and
evaluation performed at an outside hospital. PTC was inci-
dentally diagnosed in thyroid specimens obtained after thy-
Table 1: Demographics and study results.
Patients included in study 109
Patient characteristics
Gender 75.5% female
Age 54.1 years (±16.4)
BMI 29.4 (±5.3)
Primary tumor characteristics
Size 1.85cm (±1.2)
Multifocality 41%
Lymph node size (evaluated by FNA) 1.37cm (±0.53)
Average followup 34.1 months (±23.9)
Postoperative RAI scans 92% of patients
Table 2: Results of surgeon-performed ultrasound of the lateral
neck in papillary thyroid cancer.
Sensitivity 88%
Speciﬁcity 68%∗
Positive predictive value 33%∗
Negative predictive value 97%
∗All false-positive results were provenn e g a t i v eb yF N A .N op a t i e n tu n d e r -
went nontherapeutic lymph node dissection.
roidectomy for other indications, and almost all tumors were
less than 1cm in size. Some patients in the early years of the
study did not undergo surgeon-performed ultrasound as it
wasanewerdiagnosticoptionforthesurgeon.Sevenpatients
were lost to follow up before any postsurgical imagining
was obtained. Average length of followup was 34.1 (±23.9)
months.
Patientcharacteristicsrevealed75.5%female,averageage
54.1 years (±16.4), and average BMI 29.4 (±5.3). Average
primary tumor size was 1.85cm (±1.2), and 43 (41%) of
patients had multifocal PTC. Average size of lymph nodes
evaluated by 111 FNAs was 1.37cm (±0.53). Twenty-eight
modiﬁed radical neck dissections were performed on 27
patients after the initial SUS assessment. Metastatic papillary
thyroid cancer was conﬁrmed on ﬁnal pathology in all 28
dissections (Table 1).
Postoperative RAI scans were performed on almost all
patients (92%) at an average of 2.28 months after surgery.
Four patients were found to have persistent (missed) disease
in the lateral neck—three discovered with postoperative RAI
scans and one with ultrasound. All but one were conﬁrmed
with pathologic evaluation. (One of the four patients had
clearly evident lateral neck disease on posttreatment RAI
scan but failed to return to clinic for pathologic conﬁrma-
tion or additional surgical treatment.) Three patients had
recurrent disease discovered at 9, 19, and 30 months. These
patients were classiﬁed as recurrences, not persistence, and
were therefore evaluated as true negatives. Ultrasound was
the primary imaging study used for long-term surveillance.
Sensitivity, speciﬁcity, and positive and negative predic-
tive values of SUS of the lateral neck were 88%, 68%, 33%,
and97%,respectively,(Table 2).Allfalse-positiveultrasoundJournal of Oncology 3
results were proven negative by US-guided FNA. No patient
underwent a neck dissection based on a false-positive ultra-
soundresult.AllpatientswithpositiveFNAresultsindicating
metastatic papillary thyroid cancer underwent therapeutic
lateral modiﬁed radical neck lymph node dissection. Meta-
static papillary cancer was conﬁrmed in all of the surgical
specimens.
4. Discussion
Ultrasound is the recommended imaging modality for pre-
operative staging of PTC [4]. Appropriate staging is impor-
tant not only for predicting outcome but for directing surgi-
cal resection. Complete resection of all imageable disease in
the neck during the initial surgery is the best way to prevent
reoperative surgery due to persistent or recurrent disease.
Much has been published on the accuracy of ultrasound
for staging of the lateral neck in papillary thyroid cancer
[5–11]. Ultrasound imaging is traditionally performed by
radiology, not the operating surgeon. Surgeons who routi-
nely treat PTC and perform neck ultrasound and FNA are
uniquelyqualiﬁedtostagethelateralneckatthetimeofdiag-
nosis. The results of this study support surgeon-performed
ultrasound of the lateral neck in patients with papillary thy-
roid cancer.
We report both higher sensitivity (88%) and negative
predictive value (97%) than other published studies of radi-
ology-performedultrasound.Publishedsensitivitiesofultra-
sound of the lateral neck in PTC range from 51 to 83.5% in
radiology-performed studies [6, 23, 24] and as high as 93.8%
in one surgeon-performed ultrasound study [11]. Higher
sensitivity was due to liberal FNA of any dominant or suspi-
ciouslymphnode.Allfalse-positiveultrasoundﬁndingswere
proven negative by FNA. As a result, no patient underwent
unnecessary lateral neck dissection. Since FNA carries little
to no morbidity, false-positive ultrasound ﬁndings followed
byFNAallowforhighersensitivitywithoutincreasingdanger
to the patient. High sensitivity and negative predictive value
allow the surgeon to comfortably stage patients at the time of
diagnosis without fear of missing metastatic disease.
The speciﬁcity of ultrasound in this study (68%) was
lower than previously published (80 to 97%) [6, 11, 23, 24].
Positive predictive value (33%) was also lower than previ-
ously published (76.5 to 88.8%) [6, 11, 24]. Lower speciﬁcity
and positive predictive value of ultrasound are acceptable
whencombined with a liberal useof FNA since negative FNA
resultsreassurethesurgeonthatmetastaticdiseaseisnotmis-
sed. When results of FNA are added to ultrasound ﬁndings,
speciﬁcity, and positive-predictive value are higher.
Recent publications have compared the utility of US ver-
sus computed tomography (CT) versus a combination of
both to evaluate the neck in papillary thyroid cancer [9, 23–
25]. Both modalities are better at evaluating the lateral neck
as compared to the central neck. CT seems to have a poten-
tial advantage over ultrasound in evaluation of the central
neck [25]. It is common practice at our institution to per-
form routine central compartment lymph node dissection
(CLND) on all patients with a pre- or intraoperative diagno-
sis of papillary thyroid cancer [26]. When performing rou-
tine CLND, the preoperative status of the central lymph
n o d e sa ss e e no nC Ts c a nw o u l dn o ta ﬀect surgical planning.
Therefore,thispotentialadvantageofCTwouldprovidelittle
utility in our preoperative staging. Furthermore, our sensi-
tivity and negative predictive values are considerably higher
than those published for CT and combination of US and CT
in these studies (88% versus 62–77%) [23, 24].
5. Conclusion
Our results support the current American Thyroid Associa-
tion recommendations of ultrasound alone as a preoperative
staging modality. Furthermore, our data show that surgeon-
performed ultrasound of the lateral neck is reliable and
equivalent to traditional radiology-performed ultrasound by
demonstrating high sensitivity and negative predictive value.
By performing ultrasound and FNA in the clinic followed by
immediate cytopathologic evaluation, the surgeon has ﬁrst-
hand knowledge of the extent of disease preoperatively. In
addition, the patient with papillary thyroid cancer can be
examined, diagnosed, and accurately staged all during the
same visit.
References
[1] B. Aschebrook-Kilfoy, M. H. Ward, M. M. Sabra, and S. S.
Devesa, “Thyroid cancer incidence patterns in the United
States by histologic type, 1992–2006,” Thyroid,v o l .2 1 ,n o .2 ,
pp. 125–134, 2011.
[2] L.LeenhardtandP.Grosclaude,“Epidemiologyofthyroidcar-
cinoma over the world,” Annales d’Endocrinologie, vol. 72, no.
2, pp. 136–148, 2011.
[3] D.T.Hughes,M.R.Haymart,B.S.Miller,P.G.Gauger,andG.
M.Doherty,“Themostcommonlyoccurringpapillarythyroid
cancer in the United States is now a microcarcinoma in a pa-
tient older than 45 years,” Thyroid, vol. 21, no. 3, pp. 231–236,
2011.
[4] D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised
American thyroid association management guidelines for pa-
tients with thyroid nodules and diﬀerentiated thyroid cancer,”
Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009.
[5] C. L. Marshall, J. E. Lee, Y. Xing et al., “Routine pre-ope-
rative ultrasonography for papillary thyroid cancer: eﬀects on
cervical recurrence,” Surgery, vol. 146, no. 6, pp. 1063–1072,
2009.
[6] J. M. Stulak, C. S. Grant, D. R. Farley et al., “Value of preop-
erative ultrasonography in the surgical management of initial
and reoperative papillary thyroid cancer,” Archives of Surgery,
vol. 141, no. 5, pp. 489–496, 2006.
[ 7 ] H .E .G o n z´ alez, F. Cruz, A. O’Brien et al., “Impact of preoper-
ative ultrasonographic staging of the neck in papillary thyroid
carcinoma,” Archives of Otolaryngology, vol. 133, no. 12, pp.
1258–1262, 2007.
[8] J. S. Park, K. R. Son, G. N. Dong, E. Kim, and S. Kim, “Per-
formanceofpreoperativesonographicstagingofpapillarythy-
roid carcinoma based on the sixth edition of the AJCC/UICC
TNM classiﬁcation system,” American Journal of Roentgenol-
ogy, vol. 192, no. 1, pp. 66–72, 2009.
[9] Y. J. Choi, J. S. Yun, S. H. Kook, E. C. Jung, and Y. L. Park,
“Clinical and imaging assessment of cervical lymph node met-
astasis in papillary thyroid carcinomas,” World Journal of Sur-
gery, vol. 34, no. 7, pp. 1494–1499, 2010.4 Journal of Oncology
[10] M. A. Moreno, G. Agarwal, R. De Luna et al., “Preoperative
lateral neck ultrasonography as a long-term outcome predic-
torinpapillarythyroidcancer,”Archives of Otolaryngology,vol.
137, no. 2, pp. 157–162, 2011.
[11] H. S. Hwang and L. A. Orloﬀ,“ E ﬃcacy of preoperative neck
ultrasound in the detection of cervical lymph node metastasis
from thyroid cancer,” Laryngoscope, vol. 121, no. 3, pp. 487–
491, 2011.
[12] G.S.Rozycki,“Surgeon-performedultrasound:itsuseinclini-
calpractice,”AnnalsofSurgery,vol.228,no.1,pp.16–28,1998.
[13] J. B. Wilkinson, T. Boyle, J. Song, K. Kilbride, and D.
Miltenburg, “Surgeon-performed ultrasound reliably predicts
skin spacing and may decrease the rate of MammoSite balloon
catheter explantation in patients undergoing brachytherapy
for breast cancer,” American Journal of Surgery, vol. 196, no.
2, pp. 289–292, 2008.
[14] A. Lindelius, S. T¨ orngren, H. Pettersson, and J. Adami, “Role
of surgeon-performed ultrasound on further management of
patients with acute abdominal pain: a randomised controlled
clinical trial,” Emergency Medicine Journal,v o l .2 6 ,n o .8 ,p p .
561–566, 2009.
[15] S. E. Suthers, R. Albrecht, D. Foley et al., “Surgeon-directed
ultrasoundfortraumaisapredictorofintra-abdominalinjury
in children,” American Surgeon, vol. 70, no. 2, pp. 164–167,
2004.
[16] S. V. S. Soundappan, A. J. A. Holland, D. T. Cass, and A. Lam,
“Diagnostic accuracy of surgeon-performed focused abdo-
minal sonography (FAST) in blunt paediatric trauma,” Injury,
vol. 36, no. 8, pp. 970–975, 2005.
[17] C.C.Solorzano,D.M.Carneiro,M.Ramirez,T.M.Lee,andG.
L. Irvin, “Surgeon-performed ultrasound in the management
of thyroid malignancy,” American Surgeon,v o l .7 0 ,n o .7 ,p p .
576–580, 2004.
[18] S. Prasannan, G. Davies, M. Bochner, J. Kollias, and P. Maly-
cha, “Minimally invasive parathyroidectomy using surgeon-
performed ultrasound and sestamibi,” ANZ Journal of Surgery,
vol. 77, no. 9, pp. 774–777, 2007.
[19] W. M´ endez, S. E. Rodgers, J. I. Lew, R. Montano, and C. C.
Sol´ orzano, “Role of surgeon-performed ultrasound in predic-
ting malignancy in patients with indeterminate thyroid nod-
ules,” Annals of Surgical Oncology, vol. 15, no. 9, pp. 2487–
2492, 2008.
[ 2 0 ]A .A .J a b i e v ,M .H .I k e d a ,I .M .R e i s ,C .C .S o l o r z a n o ,a n dJ .I .
Lew, “Surgeon-performed ultrasound can predict diﬀerenti-
ated thyroid cancer in patients with solitary thyroid nodules,”
Annals of Surgical Oncology, vol. 16, no. 11, pp. 3140–3145,
2009.
[21] M. Milas, A. Stephen, E. Berber et al., “Ultrasonography for
the endocrine surgeon: a valuable clinical tool that enhances
diagnostic and therapeutic outcomes,” Surgery, vol. 138, no. 6,
pp. 1193–1201, 2005.
[22] A. A. Jabiev, J. I. Lew, and C. C. Solorzano, “Surgeon-per-
formed ultrasound: a single institution experience in parathy-
roid localization,” Surgery, vol. 146, no. 4, pp. 569–577, 2009.
[23] J. E. Ahn, J. H. Lee, J. S. Yi et al., “Diagnostic accuracy of
CT and ultrasonography for evaluating metastatic cervical
lymph nodes in patients with thyroid cancer,” World Journal
of Surgery, vol. 32, no. 7, pp. 1552–1558, 2008.
[ 2 4 ] E .K i m ,J .S .P a rk ,K .R .S o n ,J .H .K i m ,S .J .J e o n ,a n dD .G .N a ,
“Preoperative diagnosis of cervical metastatic lymph nodes in
papillary thyroid carcinoma: comparison of ultrasound, com-
puted tomography, and combined ultrasound with computed
tomography,” Thyroid, vol. 18, no. 4, pp. 411–418, 2008.
[25] J. S. Choi, J. Kim, J. Y. Kwak, M. J. Kim, H. S. Chang, and E.
K. Kim, “Preoperative staging of papillary thyroid carcinoma:
comparison of ultrasound imaging and CT,” American Journal
of Roentgenology, vol. 193, no. 3, pp. 871–878, 2009.
[ 2 6 ] B .M .S a d o w s k i ,S .K .S n y d e r ,a n dT .C .L a i r m o r e ,“ R o u t i n eb i -
lateral central lymph node clearance for papillary thyroid can-
cer,” Surgery, vol. 146, no. 4, pp. 696–705, 2009.